Antibiotic from San Diego’s Zavante passes Phase 3 trial – The San Diego Union-Tribune

The San Diego Union-TribuneTed Schroeder, CEO of Zavante Therapeutics, discusses how long it will take before Zavante asks the FDA for marketing approval and the growth of antibiotic-resistant superbugs, which makes new antibiotics like Zolyd necessary. Bradley J. FikesContact … and more …read more From:: San Diego News By Google News

Source

from WordPress http://ift.tt/2njLXK2
via IFTTT